http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002543167-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C41-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-178
filingDate 2000-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2002-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2002543167-A
titleOfInvention Stereospecific adjustment of hydroxyalk-1-ene compounds
abstract (57) The present invention provides a compound represented by the general formula (I) wherein X, R, R 'and n have the same meaning as in the formula (I) by an enantioselective allylation reaction of the aldehyde of the formula (II). The present invention relates to a method for stereospecifically adjusting a 4-hydroxyalk-1-ene compound having the (R) or (S) configuration of (I) [where X represents an oxygen atom, and in this case, R represents alkyl, aryl, trityl, SiR 3 [Si (alkyl) 3 ; Si (alkyl) 2 Ph], a cyclic ether, a tetrahydrofuryl group, or a group of the formula —CO—R ″ (R ″ represents an alkyl group or an aryl group). , R ′ represent a lone pair of oxygen and n is an integer of 1 or more; or X represents a nitrogen atom, wherein R is selected from a hydrogen atom, an alkyl and an aryl group, and R ′ is —CO 2 R'', -SO 2 R'', -COR'' ( '' is selected from the group of the formula alkyl group, an aryl group, or a -CF 3 group), n is an integer of 1 or more]. Embedded image
priorityDate 1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID571223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431876780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154436381
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10783664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422186484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6093473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15484354
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10888261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448348402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432957690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416016252
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157089685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421940181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414548468
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11805871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447515396
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536240

Total number of triples: 50.